Johannes Krehbiel
Biographic Data
| ID | 7789413 |
|---|---|
| NAME | Johannes Krehbiel |
| GIVEN NAMES | Johannes |
| FAMILY NAME | Krehbiel |
| SIGNATURE | KREHBIEL J |
| AFFILIATIONS | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
A prospective non-randomized controlled trial testing the effectiveness of psychotherapeutic inpatient treatment of Post-Covid-19 syndrome - study protocol
German Clinical Trial Register (DRKS), retrospectively registered 15.02.2024 DRKSID DRKS00033562
Three-Month Follow-Up of the Post-Covid Syndrome after Admission to a Specialised Post-Covid Centre—A Prospective Study Focusing on Mental Health with Patient Reported Outcome Measures (PROMs)
Our findings align with previous research, claiming severe mental health symptoms in PASC syndrome, lasting for months after infection. In-depth assessment of risk and protective factors for the mental health implications of PASC is needed for the planning of health services and disease prevention
Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-Covid syndrome
The study was registered at the German Clinical Trials Register (DRKS-ID: DRKS00033621) on March 20, 2024
No prominent works on this page.
A prospective non-randomized controlled trial testing the effectiveness of psychotherapeutic inpatient treatment of Post-Covid-19 syndrome - study protocol
German Clinical Trial Register (DRKS), retrospectively registered 15.02.2024 DRKSID DRKS00033562
Three-Month Follow-Up of the Post-Covid Syndrome after Admission to a Specialised Post-Covid Centre—A Prospective Study Focusing on Mental Health with Patient Reported Outcome Measures (PROMs)
Our findings align with previous research, claiming severe mental health symptoms in PASC syndrome, lasting for months after infection. In-depth assessment of risk and protective factors for the mental health implications of PASC is needed for the planning of health services and disease prevention
Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-Covid syndrome
The study was registered at the German Clinical Trials Register (DRKS-ID: DRKS00033621) on March 20, 2024
2019-20 coronavirus outbreak (3 works) · Coronavirus disease 2019 (COVID-19 (3 works) · Internal Medicine (3 works) · Long-Term Effects of COVID-19 (3 works) · Medicine (3 works) · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 (3 works) · Virology (3 works) · Betacoronavirus (2 works) · COVID-19 and Mental Health (2 works) · Disease (2 works)